SERA News and Press, Sera Prognostics Inc. From 06/28/22

Gainers: Endo International plc (ENDP) +95%. Agile Therapeutics (AGRX) +66%. Kezar Life Sciences (KZR) +53%. Decibel Therapeutics (DBTX) +25%. Ceragon Networks (CRNT) +23%. InflaRx (IFRX) +20%. Sutro Biopharma (STRO) +19%. Tyra Biosciences (TYRA) +17%. Oasis Petroleum (OAS) +16%. Biotricity (...

SERA PROGNOSTICS TO PRESENT AT 42nd ANNUAL WILLIAM BLAIR GROWTH STOCK CONFERENCE PR Newswire SALT LAKE CITY , June 6, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal an...

SERA PROGNOSTICS ANNOUNCES PUBLICATION OF DATA DEMONSTRATING IMPROVED PERFORMANCE OF ITS PRETRM® TEST WITH MORE PRECISE GESTATIONAL AGE PR Newswire Results show that the validated proteomics predictor has even greater predictive performance to determine risk of sp...

SERA PROGNOSTICS PRESENTS DATA DEMONSTRATING THE HEALTH AND ECONOMIC BENEFIT OF PRETRM® TESTING AT ISPOR ANNUAL MEETING PR Newswire SALT LAKE CITY , May 18, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA...

Sera Prognostics, Inc. (SERA) Q1 2022 Earnings Conference Call May 10, 2022 17:00 ET Company Participants Peter DeNardo - Investor Relations Greg Critchfield - Chairman, President and Chief Executive Officer Jay Moyes - Chief Financial Officer Conference Call Participants Patrick Donnelly - C...

Image source: The Motley Fool. Sera Prognostics, Inc. (NASDAQ: SERA) Q1 2022 Earnings Call May 10, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Sera Prognostics, Inc. (SERA) Q1 2022 Earnings Call Transcript

Sera Prognostics press release (NASDAQ:SERA): Q1 GAAP EPS of -$0.40 misses by $0.06. Revenue of $0.38M (+192.3% Y/Y) beats by $0.31M. For further details see: Sera Prognostics GAAP EPS of -$0.40 misses by $0.06, revenue of $0.38M beats by $0.31M

SERA PROGNOSTICS REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS PR Newswire SALT LAKE CITY , May 10, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by pro...

SERA PROGNOSTICS AND NEWBORN FOUNDATION PARTNER TO REDUCE RISKS ASSOCIATED WITH PRETERM BIRTH AND IMPROVE HEALTH EQUITY THROUGH THE "EVERY MOTHER, EVERY BABY" PROJECT PR Newswire Project focused on reducing maternal and neonatal mortality and morbidity by mitigating ri...

Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2022 Financial Results on May 10 PR Newswire SALT LAKE CITY , May 2, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focuse...